Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.

Cannon CS.

JAAPA. 2012 Aug;25(8):30, 32-3. No abstract available.

PMID:
22928274
[PubMed - indexed for MEDLINE]
2.

[Rhabdomyolysis associated to combined ezetimibe-statin treatment].

Piedra León M, García Unzueta MT, Otero Martínez M, Amado Señaris JA.

Rev Clin Esp. 2007 Sep;207(8):425-6. Spanish. No abstract available.

PMID:
17688879
[PubMed - indexed for MEDLINE]
3.

Risk factors for rhabdomyolysis with simvastatin and atorvastatin.

Golomb B, Evans M.

Drug Saf. 2006;29(12):1191; author reply 1191-2. No abstract available.

PMID:
17147465
[PubMed - indexed for MEDLINE]
4.

Hypernatremia due to rhabdomyolysis in a patient on statin.

Victor SM, Gnanaraj A, Abraham G, Sankardas MA.

Saudi J Kidney Dis Transpl. 2011 Sep;22(5):1037-8. No abstract available.

PMID:
21912045
[PubMed - indexed for MEDLINE]
Free Article
5.

Statin-associated acute interstitial nephritis and rhabdomyolysis.

Panchangam V.

Saudi J Kidney Dis Transpl. 2014 May;25(3):659-60. No abstract available.

PMID:
24821172
[PubMed - indexed for MEDLINE]
Free Article
6.

[Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy].

Rubí S, Duch J, Ortín J, Setoain X, Pons F.

Rev Esp Med Nucl. 2006 Nov-Dec;25(6):393. Spanish. No abstract available.

PMID:
17173790
[PubMed - indexed for MEDLINE]
7.

Rhabdomyolysis with atorvastatin and fusidic acid.

O'Mahony C, Campbell VL, Al-Khayatt MS, Brull DJ.

Postgrad Med J. 2008 Jun;84(992):325-7. doi: 10.1136/pgmj.2007.064097.

PMID:
18644925
[PubMed - indexed for MEDLINE]
8.

Statin-associated rhabdomyolysis: is there a dose-response relationship?

Holbrook A, Wright M, Sung M, Ribic C, Baker S.

Can J Cardiol. 2011 Mar-Apr;27(2):146-51. doi: 10.1016/j.cjca.2010.12.024.

PMID:
21459261
[PubMed - indexed for MEDLINE]
9.

[Metabolic rhabdomyolysis during statin therapy].

Vergely N, Leca V, Antoine JC, Germain N, Khalfallah Y, Estour B.

Rev Med Interne. 2009 Aug;30(8):711-3. doi: 10.1016/j.revmed.2008.10.336. Epub 2009 May 5. French.

PMID:
19419805
[PubMed - indexed for MEDLINE]
10.

Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials".

Rosenberg L, Uretsky S.

Circulation. 2007 Jul 3;116(1):e8; author reply e9. No abstract available.

PMID:
17606852
[PubMed - indexed for MEDLINE]
Free Article
11.

Problems in dealing with very rare adverse effects of new anticancer drugs: the example of trabectedin.

Grosso F, D'Incalci M.

Tumori. 2011 Mar-Apr;97(2):256. doi: 10.1700/667.7796. No abstract available.

PMID:
21617728
[PubMed - indexed for MEDLINE]
12.

Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.

Castro JG, Gutierrez L.

Am J Med. 2002 Apr 15;112(6):505. No abstract available.

PMID:
11959068
[PubMed - indexed for MEDLINE]
13.

Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.

Wenisch C, Krause R, Fladerer P, El Menjawi I, Pohanka E.

Am J Med. 2000 Jul;109(1):78. No abstract available.

PMID:
10991749
[PubMed - indexed for MEDLINE]
14.

Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.

Mah Ming JB, Gill MJ.

AIDS Patient Care STDS. 2003 May;17(5):207-10.

PMID:
12816614
[PubMed - indexed for MEDLINE]
15.

A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis.

Noordally SO, Sohawon S, Vanderhulst J, Duttmann R, Corazza F, Devriendt J.

Ann Saudi Med. 2012 May-Jun;32(3):309-11. doi: 10.5144/0256-4947.2012.306.

PMID:
22588445
[PubMed - indexed for MEDLINE]
16.

Intensive lipid lowering with atorvastatin in coronary disease.

Ravnskov U, Rosch PJ, Sutter MC.

N Engl J Med. 2005 Jul 7;353(1):93-6; author reply 93-6. No abstract available.

PMID:
16003834
[PubMed - indexed for MEDLINE]
17.

Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.

McAdams M, Staffa J, Dal Pan G.

Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):229-39. doi: 10.1002/pds.1535.

PMID:
18175291
[PubMed - indexed for MEDLINE]
18.

Risk factors for rhabdomyolysis with simvastatin and atorvastatin.

Ronaldson KJ, O'Shea JM, Boyd IW.

Drug Saf. 2006;29(11):1061-7.

PMID:
17061911
[PubMed - indexed for MEDLINE]
19.

Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.

Skottheim IB, Bogsrud MP, Hermann M, Retterstøl K, Åsberg A.

Mol Diagn Ther. 2011 Aug 1;15(4):221-7. doi: 10.2165/11591830-000000000-00000.

PMID:
21815705
[PubMed - indexed for MEDLINE]
20.

Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.

Magee CN, Medani SA, Leavey SF, Conlon PJ, Clarkson MR.

Am J Kidney Dis. 2010 Nov;56(5):e11-5. doi: 10.1053/j.ajkd.2010.07.011.

PMID:
20888103
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk